CLINICAL_TRIALS
ClinicalTrials.gov record update
Immunogenicity and Safety of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus and Haemophilus Influenzae Type b (DTPa-IPV/Hib) Conjugate Vaccine
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02858440
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:34.542022+00:00
- Published At
- 2019-07-19T00:00:00+00:00
- Record Updated At
- 2019-09-24
- Results Posted At
- 2019-07-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diphtheria", "Tetanus", "Pertussis", "Hepatitis B", "Haemophilus Influenzae Type b"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-09-24"- protocolSection.identificationModule.nctId
"NCT02858440"- protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety of GSK Biologicals\u0027 Combined Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus and Haemophilus Influenzae Type b (DTPa-IPV/Hib) Conjugate Vaccine"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-07-19"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.